TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2453-2463

  Borbulevych, Oleg Y ^a,b   Santhanagopolan, Sujatha M ^a,c   Hossain, Moushumi ^a   Baker, Brian M ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b QUANTUMBIO INC   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELAN A; PROTEIN DMF4; PROTEIN DMF5; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER GENE THERAPY; COMPLEX FORMATION; CROSS REACTION; CRYSTAL STRUCTURE; DRUG MECHANISM; DRUG STRUCTURE; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; CROSS REACTIONS; CRYSTALLOGRAPHY, X-RAY; GENE THERAPY; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY; MART-1 ANTIGEN; NEOPLASMS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 80052677601     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101268     Document Type: Article

References (56)

1. Rosenberg, S. A., N. P. Restifo, J. C. Yang, R. A. Morgan, and M. E. Dudley. 2008. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8: 299-308. (Pubitemid 351430867)
2. Johnson, L. A., R. A. Morgan, M. E. Dudley, L. Cassard, J. C. Yang, M. S. Hughes, U. S. Kammula, R. E. Royal, R. M. Sherry, J. R. Wunderlich, et al. 2009. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114: 535-546.
3. Morgan, R. A., M. E. Dudley, J. R. Wunderlich, M. S. Hughes, J. C. Yang, R. M. Sherry, R. E. Royal, S. L. Topalian, U. S. Kammula, N. P. Restifo, et al. 2006. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129. (Pubitemid 44547756)
4. Johnson, L. A., B. Heemskerk, D. J. Powell, Jr., C. J. Cohen, R. A. Morgan, M. E. Dudley, P. F. Robbins, and S. A. Rosenberg. 2006. Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. J. Immunol. 177: 6548-6559. (Pubitemid 44628874)
5. Goff, S. L., L. A. Johnson, M. A. Black, H. Xu, Z. Zheng, C. J. Cohen, R. A. Morgan, S. A. Rosenberg, and S. A. Feldman. 2010. Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion. Cancer Immunol. Immunother. 59: 1551-1560.
6. Ray, S., A. Chhabra, N. G. Chakraborty, U. Hegde, D. I. Dorsky, T. Chodon, E. Von Euw, B. Comin-Anduix, R. C. Koya, A. Ribas, et al; UCLA-CALTECHCHLA-USC-UCONN Consortium on Translational Program in Engineered Immunity. 2010. MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro. Clin. Immunol. 136: 338-347.
7. Jazirehi, A. R., S. Baritaki, R. C. Koya, B. Bonavida, and J. S. Economou. 2011. Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction. Cancer Res. 71: 1406-1417.
8. Borbulevych, O. Y., F. K. Insaidoo, T. K. Baxter, D. J. Powell, Jr., L. A. Johnson, N. P. Restifo, and B. M. Baker. 2007. Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. J. Mol. Biol. 372: 1123-1136. (Pubitemid 47374718)
9. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19: 395-404. (Pubitemid 28392279)
10. Skipper, J. C., P. H. Gulden, R. C. Hendrickson, N. Harthun, J. A. Caldwell, J. Shabanowitz, V. H. Engelhard, D. F. Hunt, and C. L. Slingluff Jr. 1999. Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100. Int. J. Cancer 82: 669-677. (Pubitemid 29356965)
11. Derré, L., M. Ferber, C. Touvrey, E. Devevre, V. Zoete, A. Leimgruber, P. Romero, O. Michielin, F. Lévy, and D. E. Speiser. 2007. A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide. J. Immunol. 179: 7635-7645.
12. Held, G., A. Wadle, N. Dauth, G. Stewart-Jones, C. Sturm, M. Thiel, C. Zwick, D. Dieckmann, G. Schuler, H. R. Hoogenboom, et al. 2007. MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing. Eur. J. Immunol. 37: 2008-2017. (Pubitemid 47065136)
13. Michaeli, Y., G. Denkberg, K. Sinik, L. Lantzy, C. Chih-Sheng, C. Beauverd, T. Ziv, P. Romero, and Y. Reiter. 2009. Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies. J. Immunol. 182: 6328-6341.
14. Valmori, D., J.-F. Fonteneau, C. M. Lizana, N. Gervois, D. Liénard, D. Rimoldi, V. Jongeneel, F. Jotereau, J.-C. Cerottini, and P. Romero. 1998. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J. Immunol. 160: 1750-1758. (Pubitemid 28110836)
15. Ribas, A., B. Comin-Anduix, B. Chmielowski, J. Jalil, P. De la Rocha, T. A. McCannel, M. T. Ochoa, E. Seja, A. Villanueva, D. K. Oseguera, et al. 2009. Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin. Cancer Res. 15: 6267-6276.
16. Davis-Harrison, R. L., K. M. Armstrong, and B. M. Baker. 2005. Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand. J. Mol. Biol. 346: 533-550.
17. Laugel, B., J. M. Boulter, N. Lissin, A. Vuidepot, Y. Li, E. Gostick, L. E. Crotty, D. C. Douek, J. Hemelaar, D. A. Price, et al. 2005. Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition. J. Biol. Chem. 280: 1882-1892.
18. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276: 307-326. (Pubitemid 27085611)
19. Gagnon, S. J., O. Y. Borbulevych, R. L. Davis-Harrison, R. V. Turner, M. Damirjian, A.Wojnarowicz, W. E. Biddison, and B. M. Baker. 2006. T cell receptor recognition via cooperative conformational plasticity. J. Mol. Biol. 363: 228-243. (Pubitemid 44414855)
20. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134-141. (Pubitemid 26386462)
21. Murshudov, G. N., A. A. Vagin, and E. J. Dodson. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53: 240-255. (Pubitemid 27235885)
22. Perrakis, A., T. K. Sixma, K. S. Wilson, and V. S. Lamzin. 1997. wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models. Acta Crystallogr. D Biol. Crystallogr. 53: 448-455. (Pubitemid 27340643)
23. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60: 2126-2132. (Pubitemid 41742764)
24. McRee, D. E. 1999. XtalView/Xfit - A versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125: 156-165. (Pubitemid 29402600)
25. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26: 283-291.
26. Rodriguez, R., G. Chinea, N. Lopez, T. Pons, and G. Vriend. 1998. Homology modeling, model and software evaluation: three related resources. Bioinformatics 14: 523-528. (Pubitemid 28416766)
27. Chen, V. B., W. B. Arendall, III, J. J. Headd, D. A. Keedy, R. M. Immormino, G. J. Kapral, L. W. Murray, J. S. Richardson, and D. C. Richardson. 2010. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66: 12-21.
28. Krissinel, E., and K. Henrick. 2007. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372: 774-797. (Pubitemid 47321791)
29. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24: 419-466.
30. Lawrence, M. C., and P. M. Colman. 1993. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234: 946-950. (Pubitemid 24027225)
31. Piepenbrink, K. H., B. E. Gloor, K. M. Armstrong, and B. M. Baker. 2009. Methods for Quantifying T cell Receptor Binding Affinities and Thermodynamics. Methods Enzymol. 466: 359-381.
32. Clements, C. S., M. A. Dunstone, W. A. Macdonald, J. McCluskey, and J. Rossjohn. 2006. Specificity on a knife-edge: the alphabeta T cell receptor. Curr. Opin. Struct. Biol. 16: 787-795. (Pubitemid 44827723)
33. Baxter, T. K., S. J. Gagnon, R. L. Davis-Harrison, J. C. Beck, A.-K. Binz, R. V. Turner, W. E. Biddison, and B. M. Baker. 2004. Strategic mutations in the class I major histocompatibility HLA-A2 independently affect both peptide binding and T cell receptor recognition. J. Biol. Chem. 279: 29175-29184. (Pubitemid 38915791)
34. Gagnon, S. J., O. Y. Borbulevych, R. L. Davis-Harrison, T. K. Baxter, J. R. Clemens, K. M. Armstrong, R. V. Turner, M. Damirjian, W. E. Biddison, and B. M. Baker. 2005. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants. J. Mol. Biol. 353: 556-573. (Pubitemid 41417737)
35. Marrack, P., J. P. Scott-Browne, S. Dai, L. Gapin, and J. W. Kappler. 2008. Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu. Rev. Immunol. 26: 171-203. (Pubitemid 351600374)
36. Sliz, P., O. Michielin, J.-C. Cerottini, I. Luescher, P. Romero, M. Karplus, and D. C. Wiley. 2001. Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J. Immunol. 167: 3276-3284. (Pubitemid 32852568)
37. Macdonald, W. A., Z. Chen, S. Gras, J. K. Archbold, F. E. Tynan, C. S. Clements, M. Bharadwaj, L. Kjer-Nielsen, P. M. Saunders, M. C. J. Wilce, et al. 2009. T cell allorecognition via molecular mimicry. Immunity 31: 897-908.
38. Armstrong, K. M., K. H. Piepenbrink, and B. M. Baker. 2008. Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes. Biochem. J. 415: 183-196.
39. Pittet, M. J., D. Valmori, P. R. Dunbar, D. E. Speiser, D. Liénard, F. Lejeune, K. Fleischhauer, V. Cerundolo, J.-C. Cerottini, and P. Romero. 1999. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J. Exp. Med. 190: 705-715. (Pubitemid 29428652)
40. Tynan, F. E., H. H. Reid, L. Kjer-Nielsen, J. J. Miles, M. C. J. Wilce, L. Kostenko, N. A. Borg, N. A. Williamson, T. Beddoe, A. W. Purcell, et al. 2007. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat. Immunol. 8: 268-276. (Pubitemid 46745376)
41. Lee, J. K., G. Stewart-Jones, T. Dong, K. Harlos, K. Di Gleria, L. Dorrell, D. C. Douek, P. A. Van der Merwe, E. Y. Jones, and A. J. McMichael. 2004. T cell cross-reactivity and conformational changes during TCR engagement. J. Exp. Med. 200: 1455-1466. (Pubitemid 39657293)
42. Rosenberg, S. A., and M. E. Dudley. 2009. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr. Opin. Immunol. 21: 233-240.
43. Holler, P. D., P. O. Holman, E. V. Shusta, S. O'Herrin, K. D. Wittrup, and D. M. Kranz. 2000. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc. Natl. Acad. Sci. USA 97: 5387-5392. (Pubitemid 30313728)
44. Li, Y., R. Moysey, P. E. Molloy, A.-L. Vuidepot, T. Mahon, E. Baston, S. Dunn, N. Liddy, J. Jacob, B. K. Jakobsen, and J. M. Boulter. 2005. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat. Biotechnol. 23: 349-354. (Pubitemid 41094424)
45. Holler, P. D., L. K. Chlewicki, and D. M. Kranz. 2003. TCRs with high affinity for foreign pMHC show self-reactivity. Nat. Immunol. 4: 55-62. (Pubitemid 36104709)
46. Zhao, Y., A. D. Bennett, Z. Zheng, Q. J. Wang, P. F. Robbins, L. Y. L. Yu, Y. Li, P. E. Molloy, S. M. Dunn, B. K. Jakobsen, et al. 2007. High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J. Immunol. 179: 5845-5854.
47. Haidar, J. N., B. Pierce, Y. Yu, W. Tong, M. Li, and Z. Weng. 2009. Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC. Proteins 74: 948-960.
48. Colf, L. A., A. J. Bankovich, N. A. Hanick, N. A. Bowerman, L. L. Jones, D. M. Kranz, and K. C. Garcia. 2007. How a single T cell receptor recognizes both self and foreign MHC. Cell 129: 135-146. (Pubitemid 46507586)
49. Wucherpfennig, K. W., M. J. Call, L. Deng, and R. Mariuzza. 2009. Structural alterations in peptide-MHC recognition by self-reactive T cell receptors. Curr. Opin. Immunol. 21: 590-595.
50. Feng, D., C. J. Bond, L. K. Ely, J. Maynard, and K. C. Garcia. 2007. Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat. Immunol. 8: 975-983. (Pubitemid 47300012)
51. Trautmann, L., N. Labarrière, F. Jotereau, V. Karanikas, N. Gervois, T. Connerotte, P. Coulie, and M. Bonneville. 2002. Dominant TCRValpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur. J. Immunol. 32: 3181-3190. (Pubitemid 35414875)
52. Dietrich, P. Y., F. A. Le Gal, V. Dutoit, M. J. Pittet, L. Trautman, A. Zippelius, I. Cognet, V. Widmer, P. R. Walker, O. Michielin, et al. 2003. Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J. Immunol. 170: 5103-5109. (Pubitemid 36554741)
53. Cole, D. K., F. Yuan, P. J. Rizkallah, J. J. Miles, E. Gostick, D. A. Price, G. F. Gao, B. K. Jakobsen, and A. K. Sewell. 2009. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J. Biol. Chem. 284: 27281-27289.
54. Borbulevych, O. Y., K. H. Piepenbrink, and B. M. Baker. 2011. Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics. J. Immunol. 186: 2950-2958.
55. Borbulevych, O. Y., K. H. Piepenbrink, B. E. Gloor, D. R. Scott, R. F. Sommese, D. K. Cole, A. K. Sewell, and B. M. Baker. 2009. T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity 31: 885-896.
56. Wieckowski, S., P. Baumgaertner, P. Corthesy, V. Voelter, P. Romero, D. E. Speiser, and N. Rufer. 2009. Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients. J. Immunol. 183: 5397-5406.